Puerto Rico Investors Ask Appeals Court To Overturn UBS Lawsuit Dismissal
A Puerto Rico-based duo is asking a federal appeals court to overturn a lower court's dismissal of their lawsuit against UBS Financial Services.
In the suit, Vanessa Santini Hernández and Lourdes González Gutiérrez argued the firm violated their conservative risk preferences by engaging in a 'scheme' to sell them risky bonds and securities.
The duo filed the original suit in the Puerto Rico court last February. Santini is a doctor, while González is a 79-year-old San Juan retiree who previously worked in the mortgage banking industry.
According to the complaint, they relied on UBS's counsel in investment matters, with the money invested representing their financial security. According to Santini, the firm understood her situation and desire for conservative investment objectives.
In the complaint, the plaintiffs accused UBS of selling them Puerto Rico bonds and shares of closed-end mutual funds to boost their own profits, despite these products being excessively risky.
According to the complaint, the plaintiffs were falsely told that the shares in the portfolio were PR Bonds guaranteed by the government. The plaintiffs alleged that UBS advisors 'explicitly' recommended the duo purchase the closed-end funds and bonds and continue holding the securities.
'The artificial market demand for the PR securities created by the selling scheme caused a surplus and excessive supply that far exceeded any market demand that made such investments much less worthy of credit or value and was an immediate cause of the hopeless fall of the PR bonds market and proximate cause of the breach of their contract with them and causing thus loss to the plaintiff,' the complaint read.
According to the complaint, the plaintiffs didn't suffer financially until Puerto Rico's debt growth outpaced economic growth. In a July 2012 report from the New York Federal Reserve, it asserted that putting Puerto Rico on a path 'of robust, sustainable and inclusive growth remains a work in progress,' according to an analysis from the Journal for Corporate Finance.
Within several years, credit agencies degraded several Puerto Rico bond issues to junk status, Puerto Rico defaulted on several bond commitments, and, according to NBC News, the government filed for the largest municipal bankruptcy in U.S. history in 2017. The government officially exited bankruptcy in 2022 with a massive public debt restructuring.
On June 30, a Puerto Rico superior court agreed with a UBS motion to dismiss Santini and González's case. The court cited the length of time between the alleged wrongdoing and the case itself and claimed the suit lacked details on how UBS sought to deceive the investors.
According to the judge, the complaint 'lacks particularized allegations as to what materially false or misleading misrepresentations or omissions were made by UBS, why those statements or omissions were false or misleading, when those statements or omissions were made, or who made the supposedly false or misleading misrepresentations or omissions.'
Nevertheless, the plaintiffs notified the court that it was appealing the decision to the First Circuit Court of Appeals, whose jurisdiction includes Puerto Rico.
UBS declined to comment, and an attorney for the plaintiffs didn't respond prior to publication.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Is There Now An Opportunity In TransDigm Group Incorporated (NYSE:TDG)?
Today we're going to take a look at the well-established TransDigm Group Incorporated (NYSE:TDG). The company's stock received a lot of attention from a substantial price movement on the NYSE over the last few months, increasing to US$1,621 at one point, and dropping to the lows of US$1,373. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether TransDigm Group's current trading price of US$1,388 reflective of the actual value of the large-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at TransDigm Group's outlook and value based on the most recent financial data to see if there are any catalysts for a price change. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. Is TransDigm Group Still Cheap? According to our valuation model, TransDigm Group seems to be fairly priced at around 0.57% above our intrinsic value, which means if you buy TransDigm Group today, you'd be paying a relatively fair price for it. And if you believe the company's true value is $1380.06, then there isn't really any room for the share price grow beyond what it's currently trading. Although, there may be an opportunity to buy in the future. This is because TransDigm Group's beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company's shares will likely fall by more than the rest of the market, providing a prime buying opportunity. See our latest analysis for TransDigm Group What kind of growth will TransDigm Group generate? Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. TransDigm Group's earnings over the next few years are expected to increase by 47%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value. What This Means For You Are you a shareholder? It seems like the market has already priced in TDG's positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven't considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough conviction to buy should the price fluctuates below the true value? Are you a potential investor? If you've been keeping an eye on TDG, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the optimistic prospect is encouraging for the company, which means it's worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop. Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. Be aware that TransDigm Group is showing 3 warning signs in our investment analysis and 2 of those can't be ignored... If you are no longer interested in TransDigm Group, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
27 minutes ago
- Yahoo
Trump Media's $2 Billion Bitcoin Purchase Creates Stock Surge
President Donald Trump's media group, Trump Media, made headlines in July when it purchased a staggering $2 billion in bitcoin and securities. I Asked ChatGPT To Explain TRUMP Crypto to Me Like I'm 12: Read Next: Trump Media made the bold move as a follow-up to its announcement made in May, when the company declared it had raised $2.5 billion in funding to make the purchase — all part of a plan for Trump Media to become a bitcoin treasury company, as reported by Yahoo Finance. Trump Media's Plan Devin Nunes, CEO and president of Trump Media, described the purchase as a means to '[rigorously implement] our publicly announced strategy and fulfilling our bitcoin treasury plan. These assets help insure our company's financial freedom, help protect us against discrimination by financial institutions, and will create synergies with the utility token we're planning to introduce across the Truth Social ecosphere.' Trump Media's massive bitcoin purchase not only shored up enough crypto to facilitate the company's bitcoin treasury plan, it also gave shares of Trump Media a boost in the stock market. Following the $2 billion acquisition, shares of Trump Media increased by 5.6% — or $1.04, to an overall total of $19.71 — after a bumpy 2025 that has seen the company's stock dip by 42%, per CBS News. Learn More: What It Means for You Considering investing in Trump Media? Despite its previously-rocky standing on the stock market, having its own bitcoin treasury could radically benefit the company for investors. Specifically, if bitcoin values continue to rise, so too would Trump Media's holdings, thus benefitting Trump Media shareholders. Additionally, having that massive level of liquidity helps to protect (in some degree) Trump Media investors from the kind of significant loses it had suffered earlier this year, per AInvest. Also, as Fortune noted, purchasing shares of Trump Media allows for a kind of indirect exposure to the crypto and digital-asset market, in case you're a skittish investor who doesn't want to take the full dive into the world of crypto. It's important to remember that Trump Media, President Trump and bitcoin remain volatile entities, especially in this era of economic and regulatory uncertainty. Investing in Trump Media would definitely be a speculative move — you should be aware of yours risk tolerance before betting on such combustive (but potentially rewarding) investments. What this means for investors is that while Trump Media will continue to be a high-risk investment, its level of high-reward has increased significantly with its efforts to create its own bitcoin treasury — and the financial independence that level of liquidity provides. Editor's note on political coverage: GOBankingRates is nonpartisan and strives to cover all aspects of the economy objectively and present balanced reports on politically focused finance stories. You can find more coverage of this topic on More From GOBankingRates 5 Ways Trump Signing the GENIUS Act Could Impact RetireesMark Cuban Tells Americans To Stock Up on Consumables as Trump's Tariffs Hit -- Here's What To Buy This article originally appeared on Trump Media's $2 Billion Bitcoin Purchase Creates Stock Surge Sign in to access your portfolio
Yahoo
27 minutes ago
- Yahoo
The three-year loss for CVS Health (NYSE:CVS) shareholders likely driven by its shrinking earnings
CVS Health Corporation (NYSE:CVS) shareholders should be happy to see the share price up 11% in the last month. But that doesn't change the fact that the returns over the last three years have been less than pleasing. After all, the share price is down 34% in the last three years, significantly under-performing the market. Although the past week has been more reassuring for shareholders, they're still in the red over the last three years, so let's see if the underlying business has been responsible for the decline. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. CVS Health saw its EPS decline at a compound rate of 17% per year, over the last three years. This fall in the EPS is worse than the 13% compound annual share price fall. So, despite the prior disappointment, shareholders must have some confidence the situation will improve, longer term. The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image). It's good to see that there was some significant insider buying in the last three months. That's a positive. That said, we think earnings and revenue growth trends are even more important factors to consider. It might be well worthwhile taking a look at our free report on CVS Health's earnings, revenue and cash flow. What About Dividends? When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. We note that for CVS Health the TSR over the last 3 years was -26%, which is better than the share price return mentioned above. This is largely a result of its dividend payments! A Different Perspective It's good to see that CVS Health has rewarded shareholders with a total shareholder return of 23% in the last twelve months. And that does include the dividend. Since the one-year TSR is better than the five-year TSR (the latter coming in at 5% per year), it would seem that the stock's performance has improved in recent times. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. To that end, you should learn about the 3 warning signs we've spotted with CVS Health (including 1 which is a bit unpleasant) . If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: most of them are flying under the radar). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
